A growing body of literature is demonstrating the incremental prognostic and diagnostic value of myocardial blood flow (MBF) quantification over traditional myocardial perfusion imaging (MPI). With 82 Rb PET, MBF can be conveniently added to a standard MPI study with no additional cost or radiation dose, as the required technologies have reached a level of maturity and adoption enabling routine clinical application. Nevertheless, successful implementation of MBF quantification requires optimization of specific technical factors to achieve accurate and precise MBF measurements.
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A growing body of literature is demonstrating the incremental prognostic and diagnostic value of myocardial blood flow (MBF) quantification over traditional myocardial perfusion imaging (MPI). With 82 Rb PET, MBF can be conveniently added to a standard MPI study with no additional cost or radiation dose, as the required technologies have reached a level of maturity and adoption enabling routine clinical application. Nevertheless, successful implementation of MBF quantification requires optimization of specific technical factors to achieve accurate and precise MBF measurements. 1 Example factors which have been previously investigated include pharmacologic stress hyperemia, 2 tracer administration profile, 3, 4 image reconstruction method, 5 and tracer kinetic modeling. 6 One factor which has received relatively little attention is time-frame binning of the raw data to produce dynamic image sequences from which MBF is quantified. The uninitiated may be forgiven for naively assuming that fine temporal sampling, with many short time-frames, is always advantageous over using few, long time-frames; upon further consideration of practical and physical implications, selection of the optimal time-frame binning protocol may not be trivial. A review of the literature, as summarized in Table 1 , clearly demonstrates a lack of standardization of dynamic imaging sequences in the literature.
From a practical standpoint, more sampled timeframes require more data storage and more computational power. On current clinical systems, long image reconstruction times can create a bottleneck to clinical throughput. Consider a PET system that adequately meets the needs of an oncology clinic performing wholebody FDG PET-CT with 45-minute time slots per patient. Each patient may be scanned at 10 bed positions, thus requiring reconstruction of 10 individual images. A complete cardiac perfusion study consists not only of the dynamic image sequence needed for MBF quantification, but also of static and cardiac-gated uptake images for traditional MPI interpretation, both at rest and stress states. Typically, this may include reconstructions of 15-30 dynamic time-frames, 8 cardiac phases, and 2 static images (before and after CTAC alignment), all repeated at rest and stress for a total of 50-80 images per patient. If the total reconstruction time exceeds 45 minutes, then a backlog develops which may preclude timely interpretation. Clearly, some compromises must be made for a cardiac protocol including routine MBF quantification to be clinically feasible on the same oncology system, even with state-of-the-art PET systems, where reconstruction hardware is typically underpowered for sustained patient throughput. One such compromise is to reduce the number of dynamic time-frames.
In this issue of the Journal, Lee et al. investigated the effect of varying dynamic PET time-frame lengths on MBF bias and precision, and proposed an optimal binning protocol that achieves high precision, low bias, and minimal computer resource requirements. Using computer simulations and clinical data, they propose an optimal time-frame binning protocol with minimal compromise of MBF accuracy and precision (24 9 5 seconds ? 2 9 120 seconds = 26 time-frames over 6 minutes total). Furthermore, the authors proposed a relatively simple method, using Fourier analysis of the finely sampled arterial blood time-activity curve (TAC), which can be applied to estimate the required sampling interval, T s , according to the shape of the blood TAC. They further propose an even simpler method, using the full-width at half-maximum (FWHM) of the blood peak to estimate T s . A strong linear correlation between the two metrics was demonstrated (R = 0.926).
A few points of reflection to consider:
IS SAMPLING FREQUENCY THE WHOLE STORY?
Lee et al. attributed the bias and loss of precision in MBF measurements to inadequate temporal sampling according to the Nyquist theory, but it is conceivable that several other factors may have had influence. Random coincidence events and deadtime losses must be corrected for accurate image reconstruction and quantification of tracer concentration. Depending on a specific vendor's implementation of these corrections, they may be applied as average values per time-frame, and not at fine time intervals (i.e., the PET scanner may not be accurately modeled as a simple integration over a time-frame interval). During time intervals consisting of rapidly changing activity (i.e., near the peak blood activity), these inaccuracies will be most pronounced, especially for a tracer such as 82 Rb where T s can be a substantial fraction of the 76-second half-life.
WHAT ABOUT ACCURACY?
A limitation of Lee's work is that no reference truth standard existed for evaluating the accuracy of MBF values. Instead, the highest sampling rate data (2-second time-frames) were assumed to be true. However, short time-frames consist of fewer coincidence events and therefore contain more noise, which can also lead to bias in reconstructed activity and/or MBF measurements. Nevertheless, the consistent response of the average error curves below 15 second time-frames is encouraging in this dataset, but may not be representative of other imaging systems. The use of a flow phantom 20 may be beneficial for validating MBF accuracy. 
ALTERNATIVE TRACER ADMINISTRATION?
The results of Lee et al. are most relevant to the current commercial rubidium generator system, using ''constant flow-rate'' (CF) injections that elute the generator at a fixed, high rate of saline flow to produce a relatively sharp bolus of activity, but which vary in duration and shape depending on age of the generator and requested activity. They discuss briefly the use of the so-called ''constant activity-rate'' (CA) slow-bolus administration of 82 Rb activity, which may reduce the sampling requirements further. We have previously reported an automated infusion system that delivers 82 Rb at a constant rate of activity [MBq/s] over a standard 30-second interval, regardless of generator age. 21 These consistent infusion profiles lead to more reproducible MBF measurements and improved test-retest repeatability (standard error &10%). 3, 6 Slow-bolus or CA tracer infusions may enable the ability to administer larger 82 Rb activities on count-rate-limited PET systems (e.g., fully 3D systems or BGO crystals) while avoiding saturation in the early blood-pool phase of a dynamic study. 4, 22 The scanner encounters lower peak count rates (prompt and random coincidences) and more gradual fluctuations. Thus, depending on camera vendor-specific implementation, timeaveraged deadtime, and random coincidences, corrections may be more accurate for longer time-frames.
To compare between CA and CF infusion modes, we applied Lee's methods to the test-retest MBF repeatability data previously published by our group. Table 2 . FWHM (seconds) and regression-derived sampling rate T s (seconds) of blood time-activity curve bolus using constant flow-rate and constant activity-rate elutions compared to the results of Lee et al.
FWHM (seconds)
T s (95%) (seconds) The data consisted of dynamic image sequences (9 9 10, 3 9 30, 1 9 60, 1 9 120 seconds timeframes) from a single imaging session consisting of rest-CA, rest-CF, stress-CA, and stress-CF back-to-back 82 Rb PET-CT imaging in a small cohort of 9 patients (36 scans in total). Figure 1 shows the time-activity elution profiles reported by the infusion system and the resulting blood time-activity curves. The results in Table 2 confirm broader blood peaks (larger FWHM) with CA elutions vs CF elutions. The sampling rate preserving 95% of the signal power, T s (95%), was estimated using the relationship described by Lee et al (T s (95%) = 0.753 9 FWHM ? 2.391). FWHM measures were larger in our data, even with the shorter CF infusions compared to those of Lee, likely due to longer timeframes (10 vs 2 seconds), as also demonstrated in Figure 1 of the Lee paper. These results support our hypothesis that fewer, longer time-frames (e.g., 30 seconds) might be used with the slow-bolus CA infusions without loss of precision and accuracy, if Nyquist sampling is the only factor at play. A potential down-side of longer infusion profiles is that the blood peak is extended later into the dynamic image sequence, requiring more short time-frames to accurately sample the shape of the blood peak clearance. This was evident in one of our rest-CA studies with a 72 seconds FWHM (a clear outlier in the data) which was partially attributed to 30-second intermediate timeframe sampling at the end of the blood peak.
Regardless of the infusion profile, Lee's method effectively rules out the need for \5-second time-frames using current technology, and their proposed 2-phase protocol forms a robust starting point for any laboratory looking to implement a 82 Rb PET MBF clinical protocol. Further simplification, using longer frames, may also be feasible with slow-bolus constant activity-rate infusions. 
